# ANP32B

## Overview
ANP32B, or acidic nuclear phosphoprotein 32 family member B, is a gene that encodes a multifunctional protein involved in various cellular processes, including chromatin remodeling, transcription regulation, and apoptosis. The ANP32B protein is characterized by an N-terminal leucine-rich repeat (LRR) domain and a C-terminal low-complexity acidic region (LCAR), which facilitate its interactions with other proteins and nucleic acids (Reilly2014Cracking; Matilla2005The). As a histone chaperone, ANP32B plays a crucial role in nucleosome assembly and stability, impacting gene expression and chromatin structure (Chemnitz2019The). Additionally, ANP32B is involved in the regulation of apoptosis and the AKT signaling pathway, contributing to cell survival and proliferation (Yang2016ANP32B). Clinically, alterations in ANP32B expression have been linked to cancer progression and autoimmune disorders, highlighting its significance in disease pathogenesis (Chemnitz2019The; Ohno2017Downregulation).

## Structure
ANP32B is a protein characterized by an N-terminal leucine-rich repeat (LRR) domain and a C-terminal low-complexity acidic region (LCAR). The LRR domain consists of four leucine-rich repeats and a LRR-cap, which contribute to its role in protein-protein interactions and intracellular signaling (Reilly2014Cracking; Matilla2005The). The LRR domain forms canonical parallel beta-sheet structures, which are crucial for interactions with various proteins, including CRM1, PP2Ac, and histones H3-H4 (Reilly2014Cracking).

The C-terminal LCAR is highly acidic, composed mainly of glutamic and aspartic acids, and is involved in chromatin binding and microtubule association (Reilly2014Cracking; Matilla2005The). ANP32B contains nuclear localization signals (NLS) and nuclear export signals (NES), facilitating its nucleocytoplasmic shuttling (Chemnitz2019The).

ANP32B undergoes post-translational modifications, including phosphorylation by kinases such as Casein kinase II, which are important for its function (Reilly2014Cracking). The ANP32B gene also produces an isoform, Anp32b2, through alternative splicing, which lacks a nuclear localization signal and is localized in the cytoplasm (Matilla2005The).

## Function
ANP32B is a multifunctional protein involved in several critical cellular processes. It plays a significant role in chromatin remodeling and transcription regulation by interacting with DNA-binding transcription factors such as Kruppel-like Factor 5 (KLF5) and binding to histone dimers H3-H4 and H2A-H2B. This interaction allows ANP32B to modulate gene expression by repressing KLF5-downstream gene transcription (Yu2022Roles; Reilly2014Cracking). ANP32B also functions as a histone chaperone, facilitating nucleosome assembly and stability, which is crucial for maintaining chromatin structure and regulating gene transcription (Chemnitz2019The).

In terms of cell death pathways, ANP32B acts as a negative regulator of caspase-3-dependent apoptosis, suggesting a pro-survival role in healthy cells. It inhibits caspase 3, contrasting with ANP32A's role in promoting caspase activation, and is itself a substrate of caspase 3, indicating its involvement in a feedback network for effector-caspase activation (Chemnitz2019The; Reilly2014Cracking). ANP32B is also involved in the regulation of the AKT signaling pathway, which is essential for normal cell proliferation, and its deficiency can impair cell proliferation and suppress tumor progression (Yang2016ANP32B).

## Clinical Significance
Alterations in the ANP32B gene have been implicated in various diseases, particularly in cancer and autoimmune disorders. In hepatocellular carcinoma (HCC), downregulation of ANP32B is associated with anti-apoptotic effects, contributing to tumor progression. This downregulation inhibits Bax expression and promotes Bak expression, affecting the mitochondrial apoptosis pathway, and is linked to advanced stages of HCC (Ohno2017Downregulation). In breast cancer, ANP32B is highly expressed and correlates with higher histological grades. Its deficiency impairs cell proliferation and tumor progression by affecting AKT phosphorylation, suggesting its role as an oncogene (Yang2016ANP32B).

ANP32B also plays a role in immune regulation. In mice, knockout of ANP32B leads to an increased Th17 immune response and exacerbated symptoms in an experimental autoimmune encephalomyelitis model, indicating its involvement in autoimmune conditions like multiple sclerosis (Chemnitz2019The). Additionally, a natural variant of ANP32B, D130A, impairs influenza virus replication by reducing the protein's ability to support viral polymerase activity, potentially offering some genetic protection against influenza (Staller2021A).

## Interactions
ANP32B is involved in various interactions with proteins and nucleic acids, playing significant roles in cellular processes. It interacts with the DNA-binding transcription factor Kruppel-like Factor 5 (KLF5), where it is recruited to promoter regions to repress KLF5-downstream gene transcription. This interaction involves ANP32B binding to histone dimers H3-H4 and H2A-H2B (Yu2022Roles; Reilly2014Cracking). ANP32B also demonstrates histone chaperone activity, interacting with core histones H3-H4 through its leucine-rich repeat (LRR) region (Reilly2014Cracking).

In the context of apoptosis, ANP32B acts as a negative regulator by inhibiting caspase 3 and regulating the phosphorylation of BCL2-associated agonist of cell death (Bad) and the expression of BCL2 antagonist/killer (Bak) and BCL2 associated X (Bax) (Yu2022Roles; Reilly2014Cracking). It also interacts with the nuclear-export factor CRM1 and the mRNA-binding protein HuR, facilitating nucleocytoplasmic transport (Chemnitz2019The; Reilly2014Cracking).

ANP32B is implicated in viral replication, particularly in the formation of the influenza virus RNA-dependent RNA polymerase (RdRp) complex, where it supports viral polymerase activity and the binding of complementary RNA to viral RNA (Yu2022Roles).


## References


[1. (Staller2021A) Ecco Staller, Carol M. Sheppard, Laury Baillon, Rebecca Frise, Thomas P. Peacock, Vanessa Sancho-Shimizu, and Wendy S. Barclay. A natural variant in anp32b impairs influenza virus replication in human cells. Journal of General Virology, September 2021. URL: http://dx.doi.org/10.1099/jgv.0.001664, doi:10.1099/jgv.0.001664. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1099/jgv.0.001664)

[2. (Yang2016ANP32B) S Yang, L Zhou, P T Reilly, S-M Shen, P He, X-N Zhu, C-X Li, L-S Wang, T W Mak, G-Q Chen, and Y Yu. Anp32b deficiency impairs proliferation and suppresses tumor progression by regulating akt phosphorylation. Cell Death &amp; Disease, 7(2):e2082–e2082, February 2016. URL: http://dx.doi.org/10.1038/cddis.2016.8, doi:10.1038/cddis.2016.8. This article has 26 citations.](https://doi.org/10.1038/cddis.2016.8)

[3. (Matilla2005The) Antoni Matilla and Martin Radrizzani. The anp32 family of proteins containing leucine-rich repeats. The Cerebellum, 4(1):7–18, April 2005. URL: http://dx.doi.org/10.1080/14734220410019020, doi:10.1080/14734220410019020. This article has 88 citations.](https://doi.org/10.1080/14734220410019020)

[4. (Ohno2017Downregulation) Yoshinori Ohno, Mitsuhito Koizumi, Hironao Nakayama, Takao Watanabe, Masashi Hirooka, Yoshio Tokumoto, Taira Kuroda, Masanori Abe, Shinji Fukuda, Shigeki Higashiyama, Teru Kumagi, and Yoichi Hiasa. Downregulation of anp32b exerts anti-apoptotic effects in hepatocellular carcinoma. PLOS ONE, 12(5):e0177343, May 2017. URL: http://dx.doi.org/10.1371/journal.pone.0177343, doi:10.1371/journal.pone.0177343. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0177343)

[5. (Reilly2014Cracking) Patrick T. Reilly, Yun Yu, Ali Hamiche, and Lishun Wang. Cracking the anp32 whips: important functions, unequal requirement, and hints at disease implications. BioEssays, 36(11):1062–1071, August 2014. URL: http://dx.doi.org/10.1002/bies.201400058, doi:10.1002/bies.201400058. This article has 80 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/bies.201400058)

[6. (Yu2022Roles) Mengmeng Yu, Yuxing Qu, Haili Zhang, and Xiaojun Wang. Roles of anp32 proteins in cell biology and viral replication. Animal Diseases, October 2022. URL: http://dx.doi.org/10.1186/s44149-022-00055-7, doi:10.1186/s44149-022-00055-7. This article has 5 citations.](https://doi.org/10.1186/s44149-022-00055-7)

[7. (Chemnitz2019The) Jan Chemnitz, Dorothea Pieper, Lena Stich, Udo Schumacher, Stefan Balabanov, Michael Spohn, Adam Grundhoff, Alexander Steinkasserer, Joachim Hauber, and Elisabeth Zinser. The acidic protein rich in leucines anp32b is an immunomodulator of inflammation in mice. Scientific Reports, March 2019. URL: http://dx.doi.org/10.1038/s41598-019-41269-z, doi:10.1038/s41598-019-41269-z. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-019-41269-z)